Esophagitis is a chronic disease that leads to inflammation of the esophagus. Ghrelin is a 28-amino acid peptide that has several endocrine and metabolic effects. The aim of this study was to investigate the effect of ghrelin on the esophagitis. Eighteen wistar rats were divided into three groups of six. Midline laparatomy was performed in the control group. In the gastroesophageal reflux disease (GERD) and GERD+Ghrelin groups, esophagitis was induced by method of Omura. Rats in GERD+Ghrelin group received 4 i.p. injections of 25 ng/g body weight ghrelin. The amount of gastric acid secretion and esophageal blood flow were measured. Gastric acid in GERD+Ghrelin group increased significantly when compared to control and GERD groups. The epithelium thickness and papillae of lamina properia length in GERD group increased significantly compared to the control group. The difference in papillae of lamina properia length between GERD and GERD+Ghrelin was statistically significant. Esophageal blood flow in GERD+Ghrelin group increased significantly in comparison with GERD group. Treatment with ghrelin could reduce esophageal mucosal damage followed by chronic exposure of acid and other gastric contents.
INTRODUCTION
Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder in the world known with specific symptoms such as heartburn and acid regurgitation (Klauser et al., 1990) . It has been proven that GERD is a major etiologic factor which causes inflammatory and neoplastic disorders in the upper gastrointestinal tract (Koufman, 1991) . Chronic exposure to gastric contents such as acid, pepsin, trypsin and bile acids with esophageal squamous epithelium is the main initiating factors of this processes (Dodds et al., 1982) .
In chronic reflux, gastric acid can cause several degrees of esophageal mucosal injuries like basal cell hyperplasia, mucosal thickening and lamina papillae elongation. In most patients, damaged epithelium heals through squamous cell regeneration and sometimes via a metaplastic process called Barrett's esophagus which is the major risk factor for esophageal adenocarcinoma p (Spechler, 2002) . It has been reported that GERD revalence in western countries ranges from 10 to 48 % (Heading, 1999) . Major GERD symptoms occur at least monthly in 18.4% of the urban population in Tehran district (Nouraie et al., 2007) .
Ghrelin, a 28-animo acid peptide which mainly releases from the stomach is known as endogenous ligand of growth hormone secretagogue receptor (Kojima and Kangawa, 2005) . Although, this hormone primarily stimulates growth hormone release, further studies revealed its several endocrine functions like antiinflammatory characteristics (Arvat et al., 2001; Chang et al., 2003; Xia et al., 2004) .
Ghrelin exerts its anti-inflammatory actions via inhibiting pro-inflammatory cytokines (Chang et al., 2003; Xia et al., 2004) in a set of gastrointestinal diseases such as inflammatory bowel disease in particular crohn's disease and pancratitis (DeBoer, 2011; Warzecha et al., 2010) . Therapeutic features of ghrelin are shown in animal models of colitis (Gonzalez-Rey et al., 2006; Konturek et al., 2009) . It exerts gastro protection against stress induced damage, ischemia reperfusion injury, and ethanol induced lesions (Brzozowski et al., 2004; Brzozowski et al., 2006; Konturek et al., 2006) . Golestan et al. (2011) , showed ghrelin protective effects against acetaminophen-induced liver injury in rats.
Therefore, the aim of the present study was to investigate the effects of exogenous ghrelin on histopathological changes of esophageal tissue, gastric acid secretion and esophageal blood flow in the Omura model of rat esophagitis (Golestan et al., 2011) .
MATERIALS AND METHODS
Ghrelin powder (24159; AnaSpec) was dissolved in sterile water (1mg/ml) and stored at -20°C until the day of administration. Before use, ghrelin diluted with 0.9% saline to the final concentration (25 ng/µl) for intraperitoneal administeration.
Animals
Experimental protocol was approved by the institutional care and committee of Tehran university of medical sciences. Eighteen male Wistar rats weighing 180 to 250 g were housed in 3 groups of 6 rats per cage. Rats maintained in a temperature controlled room with a 12 h light/dark cycle, and allowed to access water and standard laboratory food ad libitum. Animals were adapted for at least 7 days before starting the experiments.
GERD induction
GERD model induction was performed according to the method of Omura et al. (1999) . Rats were first anesthetized with intraperitoneal (i.p.) injection of ketamine (50 mg/kg) and xylazin (10 mg/kg) mixture after 24 h of fasting. After prep, midline laparatomy was done via sub-xyphoid approach. The transitional region between the forestomach and the glandular portion was ligated using 2 to 0 silk thread to enhance gastric acid reflux into the esophagus. The duodenum near the pylorus was wrapped with a piece of 18Fr Nelaton catheter. To prevent catheter dislodgment, Mohamadi et al. 7 edge of the catheter was sutured to the serosa layer of the pylorus using a 5 to 0 nylon thread. Rats were sacrificed 15 days post operation. Sham operated rats were used as controls. In another experiment, 6 rats with chronic reflux esophagitis received 4 i.p. injections of 25 ng/g body weight ghrelin at 5, 8, 11, and 14 days after surgery to evaluate the effects of ghrelin on inflammation development. In control group, animals received normal saline instead.
Gastric acid measurement
After GERD induction, rats had free access to food and water for 14 days except for the last 24 h of fasting period prior to the experiment. Tracheostomy was performed under general anesthesia with sodium thiopental (50 mg/kg i.p.). To prevent gastric reflux, cervical esophagus was then ligated. Laparatomy was done and a polyethylene tube (2.5 mm O.D., 10 cm length) was placed into the stomach via duodenal transverse incision. Gastric lavage was performed several times with 1 to 2 ml of 37°C normal saline. Animals were also allowed to have 30 min recovery. Basal acid secretion was measured with a digital titrator (Basic titrino, Metrohm, 749).
Blood flow measurement
Immediately after gastric content sampling, esophagus blood flow was measured with laser Doppler flow meter (Moor Instrument, VMS-LDF, UK). The probe was placed on the lower esophagus, and fixed with a special holder to measure esophageal blood flow as perfusion unit and reported as baseline percentage.
Histological assessment
At day 15, after measurement of gastric acid and esophagus blood flow, lower esophagus samples were removed and fixed in 10% buffered-formaldehyde solution. Tissue sections were stained with hematoxyline-eosin dyes and studied with Optika light microscope equipped with a digital camera. Epithelium thickness and the papillae of the lamina propria elongation into the epithelial surface were measured.
Statistical analysis
Data were expressed as mean ± SEM. One way and two way analysis of variances with Tukeys post-hock test were used to analyze differences between groups. P<0.05 was considered statistically significant. ghrelin (197.16±7.6 g) could stop GERD induced weight reduction and improved animals' weight similar to those in control group. In addition, statistical analysis showed no statistically difference between experimental groups on days 1 and day 7 (Figure 3 ).
Effects of ghrelin on esophagus blood flow
Measurement of blood flow showed no significant differences between control versus GERD animals. Intraperitoneal (Ip) injection of ghrelin significantly increased esophageal blood flow in comparison with GERD group (P<0.05) (Figure 4 ).
Effects of ghrelin on gastric acid secretion
The study results revealed no significant differences in gastric acid secretion between experimental groups 
DISCUSSION
In the present study, mild ghrelin stimulatory effects on gastric acid secretion and gastric emptying compared with control animals were showed. Increased gastric emptying may be mediated through amplified gastric movements followed by decreased acid, pepsin and other gastric contents exposed to the esophagus. In rat, ghrelin has shown to increase gastric acid secretion, frequency and intensity of gastric movements in a dose dependent manner (Masuda et al., 2000) . In ghrelin receptor knockout mice, ghrelin could not increase gastric emptying while in wild type animal, it could increase it dose dependently (Yang et al., 2013) . Ghrelin could also increase contraction or relaxation amplitude of the smooth muscle strips in the presence of electrical field stimulation in an escalating dose model (Yang et al., 2013) . Gastric emptying was also shown to be increased based on Dornonville et al. (2004) study. Mucosal blood flow plays an important role in protecting against mucosal damage. Many experimental studies have shown that exposure of gastric mucosa to potentially noxious environment results in little or no damage if adequate blood flow exists (Sorbye and Svanes, 1994) . Adequate blood flow can play its role with supplying the mucosa with oxygen, bicarbonate and nutritious substances, and removing carbon dioxide, hydrogen ions and toxic agents diffusing from the gastric lumen (Allen et al., 1993) . Mucosal hypoxia causes hydrogen ion accumulation in the mucosa followed by gastric acidification and ulcer development (Allen et al., 1993) . Mucosal acidification is an important predictor of mucosal bleeding (Fiddian-Green and Baker, 1987) . Bleeding can reduce blood flow and consequently increase gastric mucosal damage (Kwiecien et al., 2007) . Duodenal mucosal hypoxia inhibits ulcers healing (Leung et al., 1989) .
The therapeutic effect of ghrelin on gastric and duodenal ulcers is indirect and depends on the release of IGF-1 (Ceranowicz et al., 2009) . Ghrelin increases GH and IGF-1 serum levels in rats with intact pituitary gland. This effect is associated with accelerated gastric and duodenal healing. According to this study, growth hormone effects can directly and indirectly mediate through IGF-1 (Ceranowicz et al., 2009) . In this study, improved esophageal mucosal blood flow in ghrelin treated animals may be mediated through indirect IGF1stimulation. Food intake can cause weight gain, and has an important role in the regulation of gastrointestinal mucosal growth (Tabata and Johnson, 1986; Dembiński et al., 2004) .
Dietary content may have direct or indirect impact on mucosal growth (Dembinski et al., 1984) . On the other hand, starvation (Dembiński et al., 2004) or parenteral nutrition (Steiner et al., 1968) , can cause atrophy of the stomach and intestinal mucosa. Ghrelin has an orixigenic effect and is capable to increase appetite and food intake. In this study, administration of ghrelin could prevent GERD induced weight loss. This effect may partially be due to an increase in food intake. Studies also showed that ghrelin can significantly increase gastric and duodenal mucosal blood flow. As mentioned earlier, this effect maybe mediated through IGF-1 (Warzecha et al., 2006) . IGF-1 has been shown to have vasodilatory effects and can increase tissue blood flow (Walsh et al., 1996; Hasdai et al., 1998) . Delayed gastric emptying is a risk factor for GERD and affects approximately 10 to 40% of patients (Festi et al., 2009) .
Ghrelin can increase gastric emptying rate and consequently reduce gastric acid reaching to the esophagus. This phenomenon can prevent extensive damage due to gastric acid reflux. Ismail-beigi et al. (1970) reported that hyperplasia of the squamous epithelium and elongation of papillae of lamina properia are the indicative of low grade mucosal damage due to GERD. Omura et al. (1999) reported that histological changes caused by surgically induced esophagitis in rats are thickness of squamous epithelium and elongation of the papillae of the lamina properia (Figure 6 ). In the present study, treatment with ghrelin reduced the thickness of the squamous epithelium and lamina properia papillae length in comparison with GERD group. These ghrelin effects may be governed through increased mucosal blood flow and esophageal mucosal protection against damaging elements. Ghrelin antiinflammatory effects have also been shown in rat acetaminophen-induced liver injury and celiac disease model in our previous studies (Golestan et al., 2010; Nikoukar et al., 2014) . Therefore, ghrelin healing outcome in GERD induced esophagitis may also be mediated through its anti-inflammation mechanism.
In all, this study has its own shortcomings which make it rather difficult to reach a clear understanding on ghrelin possible mechanisms. The study preliminary results showed ghrelin effectiveness in GERD induced esophagitis healing process. More investigations are still needed to clarify exact mechanisms and unanswered questions.
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